WHO recommends two new drugs to treat patients with COVID-19
Study finds hydroxychloroquine delays disability for least treatable form of multiple sclerosis
13 January 2022One in ten people may still be infectious for COVID after ten days, new research indicates
14 January 2022WHO recommends two new drugs to treat patients with COVID-19
The drug baricitinib (a type of drug known as a Janus kinase (JAK) inhibitor, also used to treat rheumatoid arthritis) is strongly recommended for patients with severe or critical COVID-19 in combination with corticosteroids, says a WHO Guideline Development Group of international experts in The BMJ today.
